Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Biochemistry

• Publication date

  1977-05-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00628A023PMID 15590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase

  1977cited by this paper
• Immunologic relationship among fibrinolysins secreted by cultured mammalian tumor cells.

  1975cited by this paper
• Characteristics of fibrinolysin secreted by cultured rat breast carcinoma cells.

  1975cited by this paper
• Source theory viewpoints in deep inelastic scattering.

  1975cited by this paper
• Plasminogen-independent fibrinolysis by proteases produced by transformed chick embryo fibroblasts.

  1975cited by this paper
• Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

  1974cited by this paper
• Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.

  1974cited by this paper
• Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses.

  1974cited by this paper
• Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

  1974cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• The secretion of fibrinolysin by cultured rat ovarian tumor cells.

  1973cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

  1972cited by this paper
• [38] Gel electrofocusing

  1971cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• Selective enzyme purification by affinity chromatography.

  1968cited by this paper
• The specific mechanism of activation of human plasminogen to plasmin.

  1967cited by this paper
• ASSAY OF UROKINASE PREPARATIONS WITH THE SYNTHETIC SUBSTRATE ACETYL-L-LYSINE METHYL ESTER.

  1964cited by this paper
• Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod.

  1962cited by this paper
• A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

  1959cited by this paper
• A simple ultraviolet spectrophotometric method for the determination of protein.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC

  2025cites this paper
• Phenotypic, genomic, and transcriptomic heterogeneity in a pancreatic cancer cell line

  2024cites this paper
• Role of Mitochondrial and Cytosolic Folylpolyglutamate Synthetase in One-Carbon Metabolism and Antitumor Efficacy of Mitochondrial-Targeted Antifolates

  2024cites this paper
• Variation of extrachromosomal circular DNA in cancer cell lines

  2023cites this paper
• Genomic variations drive phenotypic heterogeneity in pancreatic cancer cells

  2022cites this paper
• Microsoft Word-SHMT2 Pharmacodynamics Manuscript final 10-7-19 FINAL

  2019cites this paper
• Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism

  2019cites this paper
• The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential

  2015cites this paper
• Targeting CDK9 by wogonin and related natural flavones potentiates the anti‐cancer efficacy of the Bcl‐2 family inhibitor ABT‐263

  2014cites this paper
• A NOVEL FUNCTION FOR AURORA B KINASE IN THE REGULATION OF P53 BY PHOSPHORYLATION

  2011cites this paper
• Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells.

  2011cites this paper
• Invasion by Human Pancreatic Cancer Cells 1

  2011cites this paper
• Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

  2010cites this paper
• Purification and properties of plasminogen activators from epithelial cells.

  2008cites this paper
• Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects

  2008cites this paper
• Kinetic analysis of cellular nucleotides correlated to growth and tPA production in perfusion cultures of human fibroblast cells

  2004cites this paper
• Isolation of a new member of DnaJ-like heat shock protein 40 (Hsp40) from human liver.

  1998cites this paper
• Use of moving aeration membrane bioreactor for the efficient production of tissue type plasminogen activator in serum free medium

  1996cites this paper
• Tissue‐type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells

  1995cites this paper
• Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.

  1993cites this paper
• Immunohistochemical analysis of plasminogen activator expression in human colorectal carcinomas: Correlation with CEA distribution and tumor cell kinetics

  1991cites this paper
• Partial purification and characterization of native plasminogen activators from bovine milk.

  1991cites this paper
• Malignant Tumor and Extravascular Coagulation

  1991cites this paper
• Hemostasis in malignancy

  1990cites this paper
• The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination

  1989cites this paper
• Interaction of glucocorticoid receptor from rat liver with protamine and arginine.

  1988cites this paper
• Rapid purification of dipeptidyl peptidase IV from rat liver plasma membrane.

  1987cites this paper
• Purification and characterization of human colony-stimulating factor 1 from human pancreatic carcinoma (MIA PaCa-2) cells.

  1987cites this paper
• Appearance of plasminogen activator activity during a synchronous cycle of a rat adenocarcinoma cell line, PA-III.

  1987cites this paper
• Plasminogen activator in psoriatic epidermis

  1986cites this paper
• A plasminogen activator from benign ovarian cystadenoma: partial purification and characterization.

  1986cites this paper
• [Proteolysis and malignant growth (review)].

  1986cites this paper
• Isolation and partial characterization of a proteinase inhibitor from human colorectal adenocarcinoma.

  1986cites this paper
• Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.

  1985cites this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cites this paper
• [Plasminogen activators: general aspects and recent developments].

  1985cites this paper
• Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.

  1985cites this paper
• Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.

  1985cites this paper
• Les activateurs du plasminogène: aspects généraux et développements récents

  1985cites this paper
• Plasminogen activator and cancer.

  1984cites this paper
• A simple spectrophotometric assay of plasminogen activator: comparison with the fibrinolytic method.

  1984cites this paper
• Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.

  1984cites this paper
• Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen.

  1984cites this paper
• Granulocyte-macrophage colony-stimulating factor from cultured normal rat kidney cell line.

  1984cites this paper
• Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor

  1984cites this paper
• Urokinase antigen in plasma: age and sex dependent variations.

  1984cites this paper
• Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas

  1984cites this paper
• Production of human plasminogen activators by cell culture

  1983cites this paper
• Purification and characterization of a melanoma cell plasminogen activator.

  1983cites this paper
• The role of plasminogen activators in metastasis.

  1983cites this paper
• [Methods of derivation and physico-chemical properties of plasminogen activators].

  1983cites this paper
• Sensitivity of cultured pancreatic carcinoma cells toAcinetobacter glutaminase-asparaginase

  1982cites this paper
• Secretion of plasminogen activator by the human macrophage‐like cell line, GCT: separation from colony‐stimulating and erythropoiesis‐enhancing activities

  1982cites this paper
• Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.

  1982cites this paper
• Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.

  1982cites this paper
• Isolation of tissue plasminogen activator from skin lesions with allergic vasculitis.

  1982cites this paper
• Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice.

  1982cites this paper
• Plasminogen activator in metastasis

  1982cites this paper
• Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

  1981cites this paper
• Isoelectric points and molecular weights of proteins : A new table

  1981cites this paper
• Binding of urokinase to plasma proteinase inhibitors.

  1980cites this paper
• Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.

  1980cites this paper
• Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate.

  1980cites this paper
• Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus.

  1980cites this paper
• Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells.

  1980cites this paper
• Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells.

  1980cites this paper
• Correlation between plasminogen activator activity of immunizing tumor cells and complement-mediated cytotoxic antibodies secreted by cloned hybrid cells.

  1980cites this paper
• The glycoprotein nature of human plasminogen activators

  1980cites this paper
• Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells.

  1980cites this paper
• Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.

  1979cites this paper
• Plasma membrane associated protease activity in human pancreatic cancer.

  1979cites this paper
• Purification of a colony-stimulating factor from cultured pancreatic carcinoma cells.

  1979cites this paper
• Immunological characterization of multiple weight forms of human cell plasminogen activators.

  1979cites this paper
• Plasminogen activator as a diagnostic marker for preneoplastic cells in human gynecologic specimens.

  1979cites this paper
• Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.

  1979cites this paper
• Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.

  1979cites this paper
• Plasminogen Activator from Cultured Cells and from Blood Plasma

  1979cites this paper
• Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.

  1979cites this paper
• Tumor markers in pancreatic cancer.

  1979cites this paper
• Plasminogen activators of psoriatic scale extracts

  1978influential citation
• Fibrinolytic Activity of Cultured Cells Derived During Ethylnitrosourea-induced Carcinogenesis of Rat Brain

  1978cites this paper
• Concomitant secretion by transformed SVWI38-VA13-2RA cells of plasminogen activator(s) and substance (s) which prevent their detection.

  1978cites this paper
• [The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].

  1978cites this paper
• Die enzymatische Kopplung von Fibrinogenese und Fibrinolyse

  1978cites this paper
• Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.

  1978cites this paper
• Bile activation of trypsinogen in carcinoma of the pancreas.

  1977cites this paper
• Bile, pancreatic cancer, and the activation of pancreatic juice.

  1977cites this paper
• Bile activation of trypsinogen in carcinoma of the pancreas.

  1977cites this paper
• Isoelectric points and molecular weights of proteins.

  1976cites this paper